期刊文献+

丙型肝炎病毒包膜区变异与感染慢性化关系的初步研究 被引量:4

Genetic variation characteristics of the envelope region of hepatitis C virus in the patients with chronic hepatitis
原文传递
导出
摘要 目的 探讨丙型肝炎病毒 (HCV)包膜区变异与其感染慢性化的关系。方法  3份HCV慢性感染者和 3份急性感染者血标本 ,采用逆转录 聚合酶链反应 (RT PCR)扩增HCV的E1区C端及E2区N端片段 (5 73bp) ,扩增产物进行克隆 ,以单链构象多态性 (SSCP)和异质性双体 (HD)分析对每份血清 30个克隆的E1 E2区准种 (quasispecies)进行筛选 ,挑选每份标本HCV的优势株与劣势株序列进行测定 ,分析非同义替换碱基数与同义替换碱基数比率 (dN dS ,间接反映选择压力 )和推导的氨基酸序列。结果 HCV慢性感染者病毒准种的复杂性和E2区dN dS明显高于急性感染者。HCV慢性感染者的E2区氨基酸替换率 (8.4 6 % )比急性感染者 (1.0 2 % )更高 ,而两者的E1区氨基酸替换率(分别为 2 .74 %和 1.0 9% )均较低。尽管HVR1变异程度更高 ,但仍存在高度保守的氨基酸位点。结论 HCV持续性感染与准种复杂性增高和宿主对HVR1的免疫选择有关。 Objective To study the association of the envelope region variation of hepatitis C virus (HCV) with the chronicity of HCV infection. Methods Acute phase plasma samples from three injection drug users who acquired HCV infecton during six month follow up and three patients with chronic hepatitis C were obtained. A 573 bp fragment containing the 5' half of E1 and 3' half of E2 were amplified by nested reverse transcription polymerase chain reaction (RT PCR). For each,30 cloned cDNAs were examined by a method that combined heteroduplex (HD) analysis and a single stranded conformational polymorphisim (SSCP) assay to assess quasispecies complexity and optimize selection of clones with unique gel shift patterns for sequencing. The ratio of nonsynonymous to synonymous substitution ( dN/dS) within each sample was evaluated as an indicator of relative selective pressure. Amino acid sequences were analyzed for signature patterns and glycosylation signals. Results Quasispecies complexity and E2 dN/dS ratio were higher in those with chronic hepatitis, in whom a trend toward more numbers of nonsynonymous mutations was detected at the E2. 1.02% (1.33/130) and 8.46% (11/130) amino acids within the E2 region mutated in chronic hepatitis and acute hepatitis, whereas within the E1 region 2.74% and 1.09% amino acids replaced among chronic and acute hepatitis,respectively. Some consistent amino acids were detected, although the hypervariable region 1 (HVR1) had a higher variability in subjects with chronic infection. Conclusion HCV persistence is associated with a complex quasispecies and host immune selection to HVR1.
作者 陈嵩 王宇明
出处 《中华实验和临床病毒学杂志》 CAS CSCD 北大核心 2002年第3期219-222,共4页 Chinese Journal of Experimental and Clinical Virology
基金 国家自然科学基金资助 (3 9870 694)
关键词 丙型肝炎病毒 包膜区 变异 感染慢性化 丙型肝炎 Hepatitis C virus Gene Variation
  • 相关文献

参考文献9

  • 1Ling TJ,Rehermann B,Seeff LB,et al.Pathagenesis,natural history,treatment and prevention of hepatitis C.Ann Inter Med,2000,132:296-305.
  • 2Zibert A,Schreier E,Roggendorf M,et al.Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.Virology,1995,208:653-661.
  • 3陈嵩,王宇明,李成明,方勇飞.静脉药瘾者丙型肝炎病毒感染的分子流行病学[J].世界华人消化杂志,2001,9(5):526-528. 被引量:11
  • 4Orland JR,Wright TL,Cooper S.Acute hepatitis C.Hepatology,2001,33:321-326.
  • 5Forns X,Thimme R,Govindarajan S,et al.Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. Proc Natl Acad Sci U S A,1996,97:13318-13323.
  • 6Ray SC,Wang YM,Laeyendecker O,et al.Acute hepatitis c virus structural gene sequences as predictors of persistent viremia:hypervariable region 1 as a decoy. J Virol,1999,73:2938-2946.
  • 7Clarke DK,Duarte SF,Elena A,et al.The red queen regions in the kingdom of RNA viruses.Proc Natl Acad Sci U S A,1994,91:4821-4824.
  • 8McAllister J,Casino C,Davidson F,et al.Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort.J Virol,1998,72:4893-4905.
  • 9Shang D,Zhai W,Allain JP.Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits.Virology,1999,258:396-405.

二级参考文献10

共引文献10

同被引文献35

  • 1杜绍财,魏来,陶其敏,冯百芳,朱凌,刘金祥.丙型肝炎病毒RNA非结构区套式聚合酶链反应[J].中华医学检验杂志,1996,19(6):354-357. 被引量:12
  • 2Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26(Suppl 1):62S-65S.
  • 3Colombo M. The role of hepatitis C virus in hepatocellular carcinoma. Recent Results Cancer Res 1998;154:337-344.
  • 4Moriguchi H, Uemura T, Kobayashi M, Chung RT, Sato C.Management strategies using pharmacogenomics in patients with severe HCV-1b infection:a decision analysis. Hepatology 2002;36:177-185.
  • 5Younossi ZM, Singer ME, McHutchison JG, Shermock KM.Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C. Hepatology 1999;30:1318-1324.
  • 6Kowala-Piaskowska A, Figlerowicz M, Mozer-Lisewska I,Mazur-Melewska K, Pawelek T, Sluzewski W. Vertical transmission of hepatitis C virus infection. Hepatol Res 2004;30:137-140.
  • 7Zeuzem S, Heathcote EJ, Shiffman ML, Wright TL, Bain VG,Sherman M, Feinman SV, Fried MW, Rasenack J, Sarrazin C,Jensen DM, Lin A, Hoffman JH, Sedarati F. Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon alpha for chronic hepatitis C. J Hepatol 2003;39:106-111.
  • 8Neumann UP, Berg T, Bahra M, Seehofer D, Langrehr JM,Neuhaus R, Radke C, Neuhaus P. Fibrosis progression afterliver transplantation in patients with recurrent hepatitis C. J Hepatol 2004;41:830-836.
  • 9Kasuno K, Ono T, Matsumori A, Nogaki F, Kusano H,Watanabe H, Yodoi J, Muso E. Hepatitis C virus-associated tubulointerstitial injury. Am J Kidney Dis 2003;41:767-775.
  • 10Hui CK, Belaye T, Montegrande K, Wright TL. A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase. J Hepatol 2003;38:511-517.

引证文献4

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部